Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Tokyo  >  ONO PHARMACEUTICAL CO., LTD.    4528   JP3197600004

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ( JPY)
Sales 2016 141 052 M
EBIT 2016 -
Net income 2016 14 285 M
Finance 2016 194 939 M
Yield 2016 1,33%
Sales 2017 161 480 M
EBIT 2017 -
Net income 2017 22 542 M
Finance 2017 188 644 M
Yield 2017 1,34%
PER 2016 98,17
PER 2017 57,55
EV / Sales 2016 9,91x
EV / Sales 2017 8,70x
Capitalization 1 593 298 M
More Financials
Company
Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of pharmaceutical and diagnostic reagents focusing on prescription pharmaceuticals.Its products include respiratory, digestive, urinary, chemotherapy, hormone, vitamins, and metabolic drugs.The company was founded by Ichibei... 
Sector
Pharmaceuticals
Calendar
08/04Earnings Release
More about the company
Surperformance© ratings of ONO PHARMACEUTICAL CO., LT
Trading Rating : Investor Rating :
More Ratings
Latest news on ONO PHARMACEUTICAL CO., LT
07/01 RECEPTOS : TSRI research leads to 3-D structures of key molecule implicated in d..
06/26 ONO PHARMACEUTICAL : Notice Concerning Issuance of Stock Options (Stock Acquisit..
06/22 ONO PHARMACEUTICAL : European Commission Approves Bristol-Myers Squibb's Opdivo ..
06/22 BRISTOL MYERS SQUIBB : New drug shows promise for cancer disease
06/12 ONO PHARMACEUTICAL : New Post Hoc Analyses of Phase 3b Data Examine Treatment wi..
06/10 ONO PHARMACEUTICAL : TECOS, the Trial Evaluating Cardiovascular Outcomes with JA..
06/03 ONO PHARMACEUTICAL : Opdivo (nivolumab) First PD-1 Inhibitor to Demonstrate Supe..
06/01 ONO PHARMACEUTICAL : Phase I/II Opdivo (nivolumab) Trial Shows Bristol-Myers Squ..
More news
Sector news : Generic Pharmaceuticals
10:43a NOVARTIS : 'More efforts needed worldwide to prevent eye diseases'
01:00a OPKO HEALTH : and Bio-Reference Laboratories Announce Early Termination of the W..
07/03 Exclusive - Hospira wins French biosimilar drug tender at 45 percent discount
More sector news : Generic Pharmaceuticals


Comments 
Advertisement
Chart ONO PHARMACEUTICAL CO., LT
Duration : Period :
ONO PHARMACEUTICAL CO., LT Technical Analysis Chart | 4528 | JP3197600004 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions